The estimated Net Worth of Monty K Allen is at least $2.45 Milion dollars as of 3 June 2024. Mr. Allen owns over 1,947 units of Iradimed Corp stock worth over $843,797 and over the last 20 years he sold IRMD stock worth over $1,451,478. In addition, he makes $154,986 as Independent Director at Iradimed Corp.
Monty has made over 22 trades of the Iradimed Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 1,947 units of IRMD stock worth $84,441 on 3 June 2024.
The largest trade he's ever made was selling 10,000 units of Iradimed Corp stock on 5 March 2019 worth over $253,900. On average, Monty trades about 2,595 units every 92 days since 2004. As of 3 June 2024 he still owns at least 18,053 units of Iradimed Corp stock.
You can see the complete history of Mr. Allen stock trades at the bottom of the page.
Monty K. Allen CPA serves as Independent Director of the Company. Mr. Allen served as Chief Financial Officer, Secretary and Treasurer of LENSAR, Inc., a medical device business from 2005 through 2011 and continued to serve LENSAR in other capacities until 2016. From 2011 to present, Mr. Allen has served several other businesses as a consultant. Mr. Allen has more than 40 years of accounting and finance experience including service as Chief Financial Officer of three publicly-held companies in biotech, medical and optical technologies. Mr. Allen is a licensed CPA in Florida. Mr. Allen received a B.S. in Accounting and International Business from Florida State University in 1974 and an M.B.A. in General Management from Harvard University in 1978.
As the Independent Director of Iradimed Corp, the total compensation of Monty Allen at Iradimed Corp is $154,986. There are 5 executives at Iradimed Corp getting paid more, with Chris Scott having the highest compensation of $587,753.
Monty Allen is 67, he's been the Independent Director of Iradimed Corp since 2014. There are 2 older and 6 younger executives at Iradimed Corp. The oldest executive at Iradimed Corp is Anthony Vuoto, 69, who is the Independent Director.
Monty's mailing address filed with the SEC is C/O IRADIMED CORPORATION, 1025 WILLA SPRINGS DR., WINTER SPRINGS, FL, 32708.
Over the last 10 years, insiders at Iradimed Corp have traded over $124,402,085 worth of Iradimed Corp stock and bought 103,100 units worth $734,768 . The most active insiders traders include Roger E. Susi, James B Hawkins a Brent Johnson. On average, Iradimed Corp executives and independent directors trade stock every 13 days with the average trade being worth of $812,855. The most recent stock trade was executed by Monty K Allen on 3 June 2024, trading 1,947 units of IRMD stock currently worth $84,441.
iradimed corporation develops, manufactures, markets, and distributes magnetic resonance imaging (mri) compatible medical devices, and related accessories and services in the united states and internationally. it offers mri compatible intravenous (iv) infusion pump system with associated disposable iv tubing sets; and mri compatible patient vital signs monitoring system. the company also provides iv poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and spo2 monitoring with sensors and accessories. it serves hospitals, acute care facilities, and outpatient imaging centers. the company sells its products through direct field sales representatives, regional sales directors, clinical support representatives, and independent distributors. iradimed corporation was incorporated in 1992 and is headquartered in winter springs, florida.
Iradimed Corp executives and other stock owners filed with the SEC include: